Materna Medical, an OBGYN platform company dedicated to protecting women's pelvic health, announced the completion of the activation of the fifteenth U.S. clinical study site participating in the pivotal EASE trial. This clinical study is evaluating the safety and effectiveness of the Prep device and will investigate whether use of the device can reduce pelvic floor damage for first-time mothers during labor and delivery.
top of page
Search
Recent Posts
See AllBy: Steven Loeb Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times...
Matterworks, Inc., developers of the world's most powerful metabolomics platform, which accelerates the discovery, development, and...
Luna, the leading provider of in-home physical therapy, has teamed up with UCI Health, to expand access to patient care by providing...
bottom of page
コメント